Pharmacology of opioid and nonopioid analgesics in chronic pain states
- PMID: 11714863
Pharmacology of opioid and nonopioid analgesics in chronic pain states
Abstract
Chronic pain represents a mixture of pathophysiologic mechanisms, a complex assortment of spontaneous and elicited pain states, and a somewhat unpredictable response to analgesics. Opioids remain the mainstay of treatment of moderate to severe chronic pain, although there is little systematic examination to guide drug selection. Cyclooxygenase inhibitors play primarily an adjunctive role in chronic pain treatment. Agents with little activity in the treatment of acute pain, such as antidepressants, antiepileptics, and i.v. administered local anesthetics, are initiated in many patients and have significant long-term efficacy in some patients with chronic pain. The N-methyl-D-aspartate antagonist ketamine and the alpha(2)-adrenergic agonist clonidine exhibit activity in patients with acute or chronic pain and reduce opioid consumption, but are often poorly tolerated due to side effects. Topical treatment with capsaicin or lidocaine exhibits efficacy in a subset of patients, and invasive intrathecal treatment with opioids as well as clonidine, neostigmine, and adenosine may have advantages in some patients. Several laboratory models have been developed to mimic chronic pain states found in humans. Nerve injury has been induced in rats by a variety of means, resulting in mechanical allodynia and thermal hyperalgesia. A number of arthritic states have also been produced by means of chronic joint inflammation in rats. The pharmacology of these neuropathic and arthritic pain models generally resembles that found in the respective human conditions. Additional models of chronic pain, particularly visceral pain, have been developed; however, the pharmacology of these models is not well established at this time.
Similar articles
-
Chronic muscle pain induced by repeated acid Injection is reversed by spinally administered mu- and delta-, but not kappa-, opioid receptor agonists.J Pharmacol Exp Ther. 2002 Sep;302(3):1146-50. doi: 10.1124/jpet.102.033167. J Pharmacol Exp Ther. 2002. PMID: 12183674
-
Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).Pain Pract. 2008 Jul-Aug;8(4):287-313. doi: 10.1111/j.1533-2500.2008.00204.x. Epub 2008 May 23. Pain Pract. 2008. PMID: 18503626
-
Prevalence of side effects of prolonged low or moderate dose opioid therapy with concomitant benzodiazepine and/or antidepressant therapy in chronic non-cancer pain.Pain Physician. 2009 Jan-Feb;12(1):259-67. Pain Physician. 2009. PMID: 19165308 Clinical Trial.
-
Adjuncts to opioid therapy.J Am Osteopath Assoc. 2002 Sep;102(9 Suppl 3):S15-21. J Am Osteopath Assoc. 2002. PMID: 12356036 Review.
-
Spinal administration of a delta opioid receptor agonist attenuates hyperalgesia and allodynia in a rat model of neuropathic pain.Eur J Pain. 2007 Aug;11(6):685-93. doi: 10.1016/j.ejpain.2006.10.008. Epub 2006 Dec 18. Eur J Pain. 2007. PMID: 17175187
Cited by
-
Effects of mu, kappa, and delta opioid receptor agonists on the function of hypothalamic-pituitary-adrenal axis in monkeys.Psychoneuroendocrinology. 2008 May;33(4):478-86. doi: 10.1016/j.psyneuen.2008.01.006. Epub 2008 Mar 5. Psychoneuroendocrinology. 2008. PMID: 18325678 Free PMC article.
-
Bidirectional effects of serum TNF alpha level and spinal p38MAPK phosphorylation on hyperalgesia variation during CFA-induced arthritis.EXCLI J. 2012 Jul 9;11:373-85. eCollection 2012. EXCLI J. 2012. PMID: 27418913 Free PMC article.
-
Chemokines: integrators of pain and inflammation.Nat Rev Drug Discov. 2005 Oct;4(10):834-44. doi: 10.1038/nrd1852. Nat Rev Drug Discov. 2005. PMID: 16224455 Free PMC article. Review.
-
Opioid facilitation of rewarding electrical brain stimulation is suppressed in rats with neuropathic pain.Anesthesiology. 2011 Mar;114(3):624-32. doi: 10.1097/ALN.0b013e31820a4edb. Anesthesiology. 2011. PMID: 21293250 Free PMC article.
-
New insights into the analgesic properties of the XCL1/XCR1 and XCL1/ITGA9 axes modulation under neuropathic pain conditions - evidence from animal studies.Front Immunol. 2022 Dec 22;13:1058204. doi: 10.3389/fimmu.2022.1058204. eCollection 2022. Front Immunol. 2022. PMID: 36618360 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical